适应症
试验速览
- 阶段
- 3 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
入选标准
- •-Patient, age 20 years or older
- •-Patients with urinary frequency and urge urinary incontinence
- •Exclusion criteria:
- •-Patients who have diseases such as dysuria or urinary retention
- •-Patients who have difficulty to void for myself
- •-Patients with other diseases which may have been related to the state of urination. (ex urinary tract infection)
- •-Patients with polyuria
- •-Patients with diseases for which treatment with anticholinergic agents is contraindicated
- •-Patients in whom precautions are required for the use of anticholinergic agents
- •-Patients who have difficulty to use transdermal medications
排除标准
- 未提供
研究者
相似试验
未知
3 期
CS-801 phase 3 long-term studyOveractive bladderJPRN-jRCT2080220026Sankyo Co.,Ltd.
未知
3 期
CS-866DM phase 3 comparative study (ORIENT)Type 2 diabetes and nephropathyJPRN-jRCT2080220027DAIICHISANKYO Co.,Ltd.
未知
3 期
CS-747S PhaseIII trialJPRN-jRCT2080221302DAIICHISANKYO Co.,Ltd.1,200
未知
3 期
AJH801 Phase III Comparative Clinical Study in individuals with essential hypertensioHypertensionJPRN-jRCT2080221447Ajinomoto Pharmaceuticals Co., Ltd.600
进行中（未招募）
1 期
A superiority study to compare the effect of Panzyga versus placebo in patients with pediatric acute-onset neuropsychiatric syndromePediatric acute-onset neuropsychiatric syndrome (PANS)MedDRA version: 25.0Level: LLTClassification code: 10086608Term: PANS Class: 100000004848CTIS2024-511673-30-00Octapharma Pharmazeutika Produktionsgesellschaft mbH92